Gyeongmin Kim, Ph.D.

Postdoctoral Fellow (Visiting)

Systemic Autoimmunity Branch

Summary

Gyeongmin Kim, Ph.D., received her doctoral degree in the Department of Molecular Immunology from Ewha Womans University, Seoul, Korea, in 2023. She joined the Systemic Autoimmunity Branch at the NIAMS as a postdoctoral fellow in 2024, where she works on the pathogenesis of autoinflammatory or autoimmune conditions in systemic lupus erythematosus (SLE).

Previously, Dr. Kim worked on osteoimmunology and bone-related diseases, focusing on the molecular interactions with osteoclasts (bone-resorbing), osteoblasts (bone-forming), chondrocytes, and immune cells in the joint. She studied the catabolic regulator of chondrocytes, which accelerates articular cartilage destruction and emphasizes the ‘osteoclast–chondrocyte crosstalk’ in osteoarthritis (OA) pathogenesis. Furthermore, her thesis demonstrated the effect of a promising DMOAD (disease-modifying OA drug).

Expanding on her dissertation work, Dr. Kim focused on translational research, especially macrophage plasticity and suppressing inflammation in inflammatory disease models such as the lipopolysaccharide (LPS)-induced sepsis model, the cecal ligation and puncture (CLP) model, and the inflammatory bowel disease (IBD) mouse model.

Research Statement

Protein citrullination is a process catalyzed by a family of calcium-dependent enzymes called peptidylarginine deiminases (PADs). Five isozymes (PAD1–4 and PAD6) have unique tissue localization and overlapping substrates and are involved in various physiological processes, including immune responses, cell signaling, and gene expression regulation.

Dr. Gyeongmin Kim studies the pathogenesis of citrullinated proteins generated by PADs in systemic lupus erythematosus (SLE). Specifically, she works on how abnormal protein citrullination and aberrant immune responses to citrullinated antigens induce innate and adaptive immune dysregulation and organ damage. She is interested in elucidating the mechanisms that efficiently suppress the PAD activity in autoimmune diseases.

Scientific Publications

5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis.

Kim J, Ryu G, Seo J, Go M, Kim G, Yi S, Kim S, Lee H, Lee JY, Kim HS, Park MC, Shin DH, Shim H, Kim W, Lee SY
Nat Commun.
2024 Feb 3;
15(1).
doi: 10.1038/s41467-024-45174-6
PMID: 38310093

IgSF11 deficiency alleviates osteoarthritis in mice by suppressing early subchondral bone changes.

Kim GM, Kim J, Lee JY, Park MC, Lee SY
Exp Mol Med.
2023 Dec;
55(12).
doi: 10.1038/s12276-023-01126-6
PMID: 38036734

Development of Anti-OSCAR Antibodies for the Treatment of Osteoarthritis.

Kim GM, Park DR, Nguyen TTH, Kim J, Kim J, Sohn MH, Lee WK, Lee SY, Shim H
Biomedicines.
2023 Oct 19;
11(10).
doi: 10.3390/biomedicines11102844
PMID: 37893216

Roles of osteoclast-associated receptor in rheumatoid arthritis and osteoarthritis.

Kim GM, Park H, Lee SY
Joint Bone Spine.
2022 Oct;
89(5).
doi: 10.1016/j.jbspin.2022.105400
PMID: 35504517

Osteoclast-associated receptor blockade prevents articular cartilage destruction via chondrocyte apoptosis regulation.

Park DR, Kim J, Kim GM, Lee H, Kim M, Hwang D, Lee H, Kim HS, Kim W, Park MC, Shim H, Lee SY
Nat Commun.
2020 Aug 28;
11(1).
doi: 10.1038/s41467-020-18208-y
PMID: 32859940

Education

Ewha Womans University 
Postdoc Fellow, Molecular Immunology (2024) 

Ewha Womans University 
Ph.D., Molecular Immunology (2023) 

Ewha Womans University 
B.S., Life science (2017)

Experience

Postdoctoral Fellowship 
National Institutes of Health, NIAMS (2024 - Present) 

Postdoctoral Fellowship 
Ewha Womans University, Korea (2024) 

Graduate Student 
Ewha Womans University, Korea (2023)

Last Updated: